Bridgeway Capital Management’s Q32 Bio QTTB Stock Holding History

Bridgeway Capital Management’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$81K	Buy	+12,613	New	+$59.9K	﹤0.01%	1150
2023 Q4	–	Sell	-10,283	Closed	-$217K	–	1427
2023 Q3	$217K	Buy	10,283 +1,666	+19%	+$34K	0.01%	1085
2023 Q2	$137K	Sell	8,617 -4,166	-33%	-$74.8K	﹤0.01%	1206
2023 Q1	$237K	Buy	12,783 +311	+2%	+$7.75K	0.01%	1074
2022 Q4	$283K	Buy	12,472 +1,389	+13%	+$36.9K	0.01%	1002
2022 Q3	$321K	Buy	11,083 +5,555	+100%	+$227K	0.01%	1017
2022 Q2	$196K	Sell	5,528 -2,778	-33%	-$94.8K	﹤0.01%	1093
2022 Q1	$454K	Buy	+8,306	New	+$516K	0.01%	961

Other funds holding QTTB

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bridgeway Capital Management's QTTB Position: Q1 2026 in Review

Bridgeway Capital Management opened a new position in Q32 Bio (QTTB) in Q1 2026: 12,613 shares worth $81K. The stake represents ﹤0.01% of the portfolio and ranks #1150 among its holdings. This is a return to the name: Bridgeway Capital Management previously reported a position in QTTB as recently as Q3 2023.

Bridgeway Capital Management first reported a position in QTTB in Q1 2022 and has held it in 8 quarters since. The position peaked at $454K in Q1 2022. 54 funds tracked by Wall St. Rank hold QTTB as of Q1 2026.

Bridgeway Capital Management held 12,613 shares of Q32 Bio worth $81K as of Q1 2026.
Q32 Bio was a new Bridgeway Capital Management position in Q1 2026.
Q32 Bio made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q1 2026, its #1150 holding.
Bridgeway Capital Management first reported a position in Q32 Bio in Q1 2022 and has held it in 8 quarters since.
Bridgeway Capital Management's Q32 Bio position peaked at $454K in Q1 2022.
54 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.